Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Arch Therapeutics Inc (OTCQB:ARTH)

0.5895
Delayed Data
As of Nov 17
 0.00 / 0.00%
Today’s Change
0.41
Today|||52-Week Range
0.89
+1.03%
Year-to-Date
No recent news for Arch Therapeutics Inc.

Today’s Trading

Previous close0.59
Today’s open0.60
Day’s range0.55 - 0.61
Volume496,877
Average volume (3 months)383,552
Market cap$90.7M
Dividend yield--
Data as of 3:57pm ET, 11/17/2017

Growth & Valuation

Earnings growth (last year)-25.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book25.49

Competitors

No competitors data available.

Financials

Next reporting dateNovember 29, 2017
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$0.00
Annual profit (last year)-$6.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Terrence W. Norchi
Chief Financial Officer &
Treasurer
Richard E. Davis
Corporate headquarters
Framingham, Massachusetts

Forecasts